This browser is no longer supported at MarketWatch. For the best MarketWatch.com experience, please update to a modern browser.

Sanofi is acquiring Vigil Neuroscience, a biotech firm focused on novel neurodegenerative disease therapies, to boost its ...

The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic ...

Sanofi said on Thursday that it would acquire Vigil Neuroscience, a clinical-stage biotech company, for $8 per share in cash, ...

McCain currently works at Kiniksa Pharmaceuticals Ltd., as Independent Director from 2018, Kiniksa Pharmaceuticals International Plc, as Independent Director from 2024, and Blueprint Medicines Corp., ...

Andretti and Marcus Ericsson drive Allegra into Indianapolis 500 as the 2022 winner and his team join the allergy brand for ...

According to the latest study from BCC Research, "Neurology Market: A BCC Research Overview" is estimated to increase from ...

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...

Aventis Energy (CSE: AVE; OTC: VBAMF) provided a comprehensive summary of exploration insights and historical data gathered ...

Getty Images / volkankovancisoy Brand recognition is a concept used in advertising and marketing to describe consumers' ability to recognize a brand through visual or auditory cues such as logos ...

Eosinophilic esophagitis (EoE) is a multifaceted disease marked by diverse clinical features, including variations in age of ...

France's finance minister criticised on Thursday a decision by French drugmaker Sanofi to invest at least $20 billion in the ...